This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The delivery order has a firm-fixed-price contract type and a potential value of $952,828.38. It is scheduled for completion on February 27, 2024. This award is not a set-aside contract. Teva Pharmaceuticals USA, Inc. has been awarded multiple prime federal contracts and delivery orders from agencies like the Department of Veterans Affairs (VA), Department of Defense (DOD), and Bureau of Prisons to provide a range of critical pharmaceutical products including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs.
Generated 5/23/24, 9:59 AM